全文获取类型
收费全文 | 22357篇 |
免费 | 1470篇 |
国内免费 | 108篇 |
专业分类
耳鼻咽喉 | 281篇 |
儿科学 | 530篇 |
妇产科学 | 451篇 |
基础医学 | 2784篇 |
口腔科学 | 740篇 |
临床医学 | 1857篇 |
内科学 | 5724篇 |
皮肤病学 | 479篇 |
神经病学 | 1844篇 |
特种医学 | 511篇 |
外科学 | 3796篇 |
综合类 | 135篇 |
一般理论 | 8篇 |
预防医学 | 1397篇 |
眼科学 | 644篇 |
药学 | 1186篇 |
1篇 | |
中国医学 | 50篇 |
肿瘤学 | 1517篇 |
出版年
2023年 | 164篇 |
2022年 | 331篇 |
2021年 | 760篇 |
2020年 | 394篇 |
2019年 | 667篇 |
2018年 | 841篇 |
2017年 | 470篇 |
2016年 | 539篇 |
2015年 | 675篇 |
2014年 | 913篇 |
2013年 | 1099篇 |
2012年 | 1852篇 |
2011年 | 1915篇 |
2010年 | 1024篇 |
2009年 | 933篇 |
2008年 | 1489篇 |
2007年 | 1541篇 |
2006年 | 1401篇 |
2005年 | 1309篇 |
2004年 | 1111篇 |
2003年 | 961篇 |
2002年 | 898篇 |
2001年 | 184篇 |
2000年 | 164篇 |
1999年 | 215篇 |
1998年 | 197篇 |
1997年 | 145篇 |
1996年 | 127篇 |
1995年 | 137篇 |
1994年 | 125篇 |
1993年 | 119篇 |
1992年 | 119篇 |
1991年 | 92篇 |
1990年 | 78篇 |
1989年 | 68篇 |
1988年 | 58篇 |
1987年 | 61篇 |
1986年 | 62篇 |
1985年 | 51篇 |
1984年 | 64篇 |
1983年 | 48篇 |
1982年 | 63篇 |
1981年 | 60篇 |
1980年 | 45篇 |
1979年 | 42篇 |
1978年 | 34篇 |
1977年 | 37篇 |
1976年 | 35篇 |
1974年 | 26篇 |
1973年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Norihiko Kamioka Vasilis Babaliaros Michael Andrew Morse Tiberio Frisoli Stamatios Lerakis Jose Miguel Iturbe Jose Binongo Frank Corrigan Altayyeb Yousef Patrick Gleason John A. Wells Hope Caughron Andy Dong Evelio Rodriguez Bradley Leshnower William O’Neill Gaetano Paone Marvin Eng Adam Greenbaum 《JACC: Cardiovascular Interventions》2018,11(12):1131-1138
Objectives
There are minimal data regarding clinical outcomes and echocardiographic findings after transcatheter mitral valve-in-valve replacement (TMVR) compared with redo surgical mitral valve replacement (SMVR).Background
TMVR therapy has emerged as therapy for a degenerated bioprosthetic valve failure.Methods
The authors retrospectively identified patients with degenerated mitral bioprostheses who underwent redo SMVR or TMVR at 3 U.S. institutions. The authors compared clinical and echocardiographic outcomes of patients who had TMVR with those of patients who underwent redo SMVR.Results
Sixty-two patients underwent TMVR and 59 patients underwent SMVR during the study period. Mean age and the Society of Thoracic Surgeons Predicted Risk of Mortality (STS PROM) scores were significantly higher in patients with TMVR than in those with SMVR (age 74.9 ± 9.4 years vs. 63.7 ± 14.9 years; p < 0.001; STS PROM 12.7 ± 8.0% vs. 8.7 ± 10.1%; p < 0.0001). Total procedure time, intensive care unit hours, and post-procedure length of stay were all significantly shorter in the TMVR group. There was no difference in mortality at 1 year between the 2 groups (TMVR 11.3% vs. SMVR 11.9%; p = 0.92). Mean mitral valve pressure gradient and the grade of mitral regurgitation (MR) were similar between the TMVR group and the SMVR group (mitral valve pressure gradient 7.1 ± 2.5 mm Hg vs. 6.5 ± 2.5 mm Hg; p = 0.42; MR [≥moderate] 3.8% vs. 5.6%; p = 1.00) at 30 days. At 1 year, the mitral valve pressure gradient was higher in the TMVR group (TMVR 7.2 ± 2.7 vs. SMVR 5.5 ± 1.8; p = 0.01), although there was no difference in the grade of MR.Conclusions
Despite the higher STS PROM in TMVR patients, there was no difference in 1-year mortality between the TMVR and SMVR groups. Echocardiographic findings after TMVR were similar to SMVR at 30 days. There was a statistically significant difference in mitral gradient at 1 year, though this is likely not clinically important. TMVR may be an alternative to SMVR in patients with previous mitral bioprosthetic valves. 相似文献992.
Left ventricular deformation at rest predicts exercise‐induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea
下载免费PDF全文
![点击此处可从《European journal of heart failure》网站下载免费的PDF全文](/ch/ext_images/free.gif)
993.
Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study
下载免费PDF全文
![点击此处可从《Cardiovascular therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
994.
Vanessa Fontana Pamela S. Silva Tatiane C. Izidoro-Toledo Celso Biagi Eduardo B. Oliveira Raquel F. Gerlach Jose E. Tanus-Santos 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2012,26(6):511-519
Purpose
Angiotensin-converting enzyme inhibitors (ACEi) may downregulate matrix metalloproteinases (MMPs). We examined whether enalapril affects MMP-2, MMP-8, and MMP-9 levels and activity, and their endogenous inhibitors (tissue inhibitors of MMPs, TIMP-1 and TIMP-2) levels in hypertensive patients. Moreover, we assessed the effects of enalaprilat on MMP-9 and TIMP-1 secretion by human endothelial cells (HUVECs).Methods
Thirty-eight hypertensive patients received enalapril for 8 weeks and were compared with thirty-eight normotensive controls. Blood samples were collected at baseline and after treatment. Plasma ACE activity was determined by a fluorimetric assay. Plasma MMP-2, MMP-8, MMP-9, TIMP-1, and TIMP-2 were measured by ELISA and gelatin zymography. A fluorogenic peptide cleavage assay was used to measure MMP activity. HUVECs cells were stimulated by phorbol-12-myristate-13-acetate (PMA) and the effects of enalaprilat (10?10 to 10?6?M) on MMP-9 and TIMP-1 levels were determined.Results
Enalapril decreased blood pressure and ACE activity in hypertensive patients (P?<?0.05), but had no effects on plasma MMP-2, MMP-8, MMP-9, TIMP-1, and TIMP-2 levels, or MMP activity. Enalaprilat had no effects on PMA-induced increases in MMP-9 and TIMP-1 secretion by HUVECs or on MMP activity.Conclusions
We show consistent evidence, both in vivo and in vitro, that enalapril does not affect MMPs and TIMPs levels in hypertensive patients.995.
996.
997.
Marloe Prince Jose D. Tafur Christopher J. White 《JACC: Cardiovascular Interventions》2019,12(6):505-517
Atherosclerotic renal artery stenosis is the leading cause of secondary hypertension and may lead to resistant (refractory) hypertension, progressive decline in renal function, and cardiac destabilization syndromes (pulmonary edema, recurrent heart failure, or acute coronary syndromes) despite guideline-directed medical therapy. Although randomized controlled trials comparing medical therapy with medical therapy and renal artery stenting have failed to show a benefit for renal artery stenting, according to comparative effectiveness reviews by the Agency for Healthcare Research and Quality, the trials may not have enrolled patients with the most severe atherosclerotic renal artery stenosis, who would be more likely to benefit from renal stenting. Because of limitations of conventional angiography, it is critical that the hemodynamic severity of moderately severe (50% to 70%) atherosclerotic renal artery stenosis lesions be confirmed on hemodynamic measurement. The authors review techniques to optimize patient selection, to minimize procedural complications, and to facilitate durable patency of renal stenting. The authors also review the current American College of Cardiology and American Heart Association guidelines and the Society for Cardiovascular Angiography and Interventions appropriate use criteria as they relate to renal stenting. 相似文献
998.
Daniela Martínez Felipe Salech Van Nicolette Sint Jan Tomás Regueira Eli Villalabeitia Jorge Rufs Christian Fajardo Roberto Castillo Jose Iñiguez Luisa Durán Rodrigo Díaz 《Journal of artificial organs》2021,24(2):287-292
Journal of Artificial Organs - At July 25, 2020, WHO had recorded more than 16.1 million confirmed COVID-19 cases, 1% of them developed critical illness. These patients can experience rapid... 相似文献
999.
de Paula Reis Michelle de Lima Daniely Alves Pauli Karoline Bach Andreotti Carlos Eduardo Linhares de Moraes André Luiz Soares Gonçalves Daniela Dib Navarro Italmar Teodorico Bueno Paulo Sérgio Alves Seixas Flavio Augusto Vicente Gasparotto Junior Arquimedes Lourenço Emerson Luiz Botelho 《Parasitology research》2018,117(5):1465-1471
Parasitology Research - Toxoplasmosis is a zoonosis of worldwide distribution. Currently, two drugs, pyrimethamine and sulfadiazine, are used as a reference in the treatment of toxoplasmosis, but... 相似文献
1000.
Wen F Abdalla MY Aloman C Xiang J Ahmad IM Walewski J McCormick ML Brown KE Branch AD Spitz DR Britigan BE Schmidt WN 《Journal of medical virology》2004,72(2):230-240
Hepatitis C virus (HCV) and HCV core protein are hypothesized to induce hepatic oxidative stress and exacerbate injury caused by other toxins such as ethanol that induce the cytochrome P450 enzyme, CYP2E1. In the current study, the effects of HCV core protein [sequence genotype 1b, (nt 342-915)] on parameters indicative of oxidative stress were evaluated in HepG2 cells stably over expressing CYP2E1 (E47), or vector controls (C34). Stable (>10 passages) expression of HCV core protein and CYP2E1 was confirmed in clonal cell lines at the level of mRNA and immunoreactive protein. Prooxidant production, as determined by cellular oxidation of dichlorodihydrofluorescin and dihydroethidium (HE), was increased by expression of HCV core protein in the presence or absence of CYP2E1. Depletion of glutathione (GSH) with buthionine sulfoximine (BSO) enhanced prooxidant production in both C34 and E47 cells. In addition, prooxidant production was greater in BSO-treated cells expressing HCV core protein, and this effect was further enhanced in cells expressing both HCV core and CYP2E1. The CYP2E1 inhibitor, 4-methylpyrazole, could suppress increased prooxidant production in E47 cells. Finally, cells co-expressing both CYP2E1 and HCV core protein showed significantly decreased viability following GSH depletion. These studies show simultaneous expression of HCV core protein and CYP2E1 increases parameters indicative of oxidative stress as well as sensitization to cell injury induced by GSH depletion. These results support the hypothesis that enhanced injury in hepatocytes over expressing both HCV core protein and CYP2E1 is mediated by increases in oxidative stress. 相似文献